{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:15:56Z","timestamp":1789193756773,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd006401.pub4","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T00:00:00Z","timestamp":1573084800000}}],"reference-count":118,"publisher":"Wiley","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd006401.pub5","type":"journal-article","created":{"date-parts":[[2019,11,7]],"date-time":"2019-11-07T06:54:53Z","timestamp":1573109693000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":48,"title":["Statins for children with familial hypercholesterolemia"],"prefix":"10.1002","author":[{"given":"Alpo","family":"Vuorio","sequence":"first","affiliation":[{"name":"University of Helsinki; Department of Forensic Medicine; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaana","family":"Kuoppala","sequence":"additional","affiliation":[{"name":"University of Helsinki; Helsinki Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petri T","family":"Kovanen","sequence":"additional","affiliation":[{"name":"Wihuri Research Institute; Kalliolinnatie 4 Helsinki Finland FIN-00140"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Humphries","sequence":"additional","affiliation":[{"name":"BHF Laboratories, Royal Free and University College Medical School; Center for Cardiovascular Genetics; The Rayne Institute 5 University Street London UK WC1E 6JJ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Tonstad","sequence":"additional","affiliation":[{"name":"Ullev\u00e5l University Hospital; Dept. of Preventive Cardiology; Olso Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wiegman","sequence":"additional","affiliation":[{"name":"Academic Medical Center; Department of Pediatrics; Meibergdreef 9 Amsterdam Netherlands 1105 AZ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Euridiki","family":"Drogari","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens, Medical School; Unit of Metabolic Disorders, First Department of Pediatrics; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Ramaswami","sequence":"additional","affiliation":[{"name":"Royal Free Hospital; Lysosomal Unit; London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,11,7]]},"reference":[{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0001|cit1","first-page":"1121","article-title":"Efficacy and safety of rosuvastatin therapy for children with familial hypercholesterolemia","volume":"55","author":"Avis","year":"2010","journal-title":"Pediatric Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jpeds.2015.05.006","article-title":"Efficacy and safety of pitavastatin in children and adolescents at high future cardiovascular risk","volume":"167","author":"Braaskamp","year":"2015","journal-title":"Journal of Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub5-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1542\/peds.2004-2090","article-title":"Pediatrics Efficacy and safety of lovastatin therapy in adolescent girls with heterozygous familial hypercholesterolemia","volume":"116","author":"Clauss","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","article-title":"Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadian with heterozygous familial hypercholesterolemia","volume":"18","author":"Couture","year":"1998","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"issue":"32","key":"10.1002\/14651858.CD006401.pub5-BIB0005|cit5","first-page":"157","article-title":"Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolaemia: rationale, design, and baseline characteristics","volume":"11","author":"Jongh","year":"2003","journal-title":"Clinical Biochemistry and Metabolism"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub5-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"Jongh","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD006401.pub5-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1161\/01.CIR.0000035247.42888.82","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: A randomized, double-blind, placebo-controlled trial with simvastatin","volume":"106","author":"Jongh","year":"2002","journal-title":"Circulation"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub5-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2165\/00044011-200222080-00005","article-title":"Efficacy, safety and tolerability of simvastatin in children with familial hypercholesterolaemia","volume":"22","author":"Jongh","year":"2002","journal-title":"Clinical Drug Investigation"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1203\/00006450-199605000-00021","article-title":"Short-term efficacy and safety of pravastatin in 72 children with familial hypercholesterolemia","volume":"39","author":"Knipscheer","year":"1996","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0022-3476(03)00186-0","article-title":"Efficacy and safety of atorvastatin in children and adolescents with a familial hypercholesterolemia or severe hyperlipidemia: A multicenter, randomized, placebo-controlled trial","volume":"143","author":"McCrindle","year":"2003","journal-title":"Journal of Pediatrics"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1001\/jama.281.2.137","article-title":"Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia","volume":"281","author":"Stein","year":"1999","journal-title":"JAMA"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub5-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0021-9150(02)00005-9","article-title":"Long-term treatment with atorvastatin in adolescent males with heterozygous familial hypercholesterolemia","volume":"163","author":"Athyros","year":"2002","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.atherosclerosis.2015.05.034","article-title":"Gonadal steroids, gonadotropins and DHEAS in young adults with familial hypercholesterolemia who had initiated statin therapy in childhood","volume":"241","author":"Braamskamp","year":"2015","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jacl.2015.07.011","article-title":"Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study","volume":"9","author":"Braaskamp","year":"2015","journal-title":"Journal of Clinical Lipidology"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2165\/11591650-000000000-00000","article-title":"Long-term follow-up of statin treatment in a cohort of children with familial hypercholesterolemia: Efficacy and tolerability","volume":"13","author":"Carreau","year":"2011","journal-title":"Pediatric Drugs"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub5-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.numecd.2016.07.012","article-title":"Effect of omega-3 fatty acid supplementation on arterial elasticity in patients with familial hypercholesterolaemia on statin therapy","volume":"26","author":"Chan","year":"2016","journal-title":"Nutrition, Metabolism and Cardiovascular Diseases"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00431-003-1181-3","article-title":"The effect of low-dose simvastatin in children with familial hypercholesterolemia: a 1-year observation","volume":"162","author":"Dirisamer","year":"2003","journal-title":"European Journal of Pediatrics"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00246-011-9885-z","article-title":"An eight-week trial investigating the efficacy and tolerability of atorvastatin for children and adolescents with heterozygous familial hypercholesterolemia","volume":"32","author":"Gandelman","year":"2011","journal-title":"Pediatric Cardiology"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"422","DOI":"10.5551\/jat.42242","article-title":"Efficacy and safety of pitvastatin in children and adolescents with familial hypercholesterolemia in Japan and Europe","volume":"25","author":"Harada-Shiba","year":"2018","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S0009-9236(03)00153-X","article-title":"Pharmacokinetics and pharmacodynamics of pravastatin in children with familial hypercholesterolemia","volume":"74","author":"Hedman","year":"2003","journal-title":"Clinical Pharmacology and Therapy"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1210\/jc.2004-1541","article-title":"Efficacy and safety of pravastatin in children and adolescents with heterozygous familial hypercholesterolemia: A prospective clinical follow-up study","volume":"90","author":"Hedman","year":"2005","journal-title":"Journal of Clinical Endocrinology and Metabolism"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1542\/peds.97.5.619","article-title":"Treatment of familial hypercholesterolemia in children and adolescents: Effect of lovastatin","volume":"97","author":"Lambert","year":"1996","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jacl.2016.05.010","article-title":"A 3-year study of atorvastatin in children and adolescents with heterozygous familial hypercholesterolemia","volume":"10","author":"Langslet","year":"2016","journal-title":"Journal of Clinical Lipidology"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1203\/00006450-200206000-00009","article-title":"A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia","volume":"51","author":"McCrindle","year":"2002","journal-title":"Pediatric Research"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0021-9150(96)06007-8","article-title":"Statin therapy in a kindred with both apolipoprotein B and low-density lipoprotein receptor gene defects","volume":"129","author":"Raal","year":"1997","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","article-title":"Professional athletes suffering from familial hypercholesterolemia rarely tolerate statin treatment because of muscular problems","volume":"57","author":"Sinzinger","year":"2004","journal-title":"British Journal of Clinical Pharmacology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0028|cit28","first-page":"23","article-title":"Diet only and diet plus simvastatin in the treatment of heterozygous familial hypercholesterolemia in childhood","volume":"25","author":"Stefanutti","year":"1999","journal-title":"Drugs Under Experimental and Clinical Research"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006401.pub5-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"l145","DOI":"10.1016\/0021-9150(89)90171-8","article-title":"Treatment of familial hypercholesterolemia with drugs in children","volume":"9","author":"Stein","year":"1989","journal-title":"Arteriosclerosis"},{"issue":"13","key":"10.1002\/14651858.CD006401.pub5-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0735-1097(16)31856-3","article-title":"A randomized, double-blind, placebo-controlled, multi-center, Cross-over study of rosuvastatin in children and adolescents (aged 6 to <18 years) with homozygous familial hypercholesterolemia (HOFH)","volume":"67","author":"Stein","year":"2016","journal-title":"JACC"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s12944-016-0238-z","article-title":"Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy","volume":"15","author":"Tada","year":"2016","journal-title":"Lipids in Health and Disease"},{"issue":"9","key":"10.1002\/14651858.CD006401.pub5-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1253\/circj.CJ-16-0387","article-title":"Efficacy and safety of alirocumab in Japanese patients With heterozygous familial hypercholesterolemia or at high cardiovascular risk with hypercholesterolemia not adequately controlled with statins - ODYSSEY JAPAN Randomized Controlled Trial","volume":"80","author":"Teramoto","year":"2016","journal-title":"Ciruculation Journal"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1080\/08035250600702602","article-title":"Efficacy and safety of fluvastatin in children and adolescents with heterozygous familial hypercholesterolemia","volume":"95","author":"Graaf","year":"2006","journal-title":"Acta Paediatrica"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2006.09.030","article-title":"Statin treatment for children and adolescents with heterozygous familial hypercholesterolaemia: A systematic review and meta-analysis","volume":"195","author":"Arambepola","year":"2007","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub5-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1161\/ATVBAHA.107.145151","article-title":"A systematic review and meta-analysis of statin therapy in children with familial hypercholesterolemia","volume":"27","author":"Avis","year":"2007","journal-title":"Arteriosclerosis Thrombosis and Vascular Biology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1177\/106002800303700220","article-title":"Association of HMG-CoA reductase inhibitors with neuropathy","volume":"37","author":"Backes","year":"2003","journal-title":"Annals of Pharmacotherapy"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub5-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"6C","DOI":"10.1016\/j.amjcard.2005.12.006","article-title":"Statin safety: An overview an assessment of the data - 2005","volume":"97","author":"Bays","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD006401.pub5-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98 098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"European Heart Journal"},{"issue":"10","key":"10.1002\/14651858.CD006401.pub5-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archinte.1991.00400010067008","article-title":"Expanded clinical evaluation of lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia","volume":"151","author":"Bradford","year":"1991","journal-title":"Archives of Internal Medicine"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub5-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"86C","DOI":"10.1016\/j.amjcard.2005.12.017","article-title":"National Lipid Association Statin Safety Task Force Neurology Expert Panel: An assessment of statin safety by neurologist","volume":"97","author":"Brass","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0039-6257(96)82007-8","article-title":"Cholesterol and cataracts","volume":"40","author":"Cenedella","year":"1996","journal-title":"Survey of Opthalmology"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1053\/j.gastro.2004.02.015","article-title":"Patients with elevated liver enzymes are not at higher risk for statin hepatotoxicity","volume":"126","author":"Chalasani","year":"2004","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.annepidem.2009.10.007","article-title":"Persistence with statins and incident cataract: a population-based historical cohort study","volume":"20","author":"Chodick","year":"2010","journal-title":"Annals of Epidemiology"},{"issue":"9","key":"10.1002\/14651858.CD006401.pub5-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1592\/phco.24.13.1194.38084","article-title":"Statin-associated peripheral neuropathy: Review of the literature","volume":"24","author":"Chong","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD006401.pub5-BIB0046|cit46","first-page":"S77","article-title":"An assessment of statin safety by hepatologists","volume":"8","author":"Cohen","year":"2007","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1542\/peds.2008-1349","article-title":"Lipid screening and cardiovascular health in children","volume":"122","author":"Daniels","year":"2008","journal-title":"Pediatrics"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1592\/phco.24.6.584.34738","article-title":"Statins and live toxicity: a meta-analysis","volume":"24","author":"Denus","year":"2004","journal-title":"Pharmacotherapy"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub5-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1016\/S0735-1097(02)02593-7","article-title":"Early statin therapy restores endothelial function in children with familial hypercholesterolemia","volume":"40","author":"Jongh","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.atherosclerosis.2011.06.016","article-title":"Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization","volume":"218","author":"Descamps","year":"2012","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ajo.2011.08.001","article-title":"Recent statin use and cataract surgery","volume":"153","author":"Fong","year":"2012","journal-title":"American Journal of Opthalmology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2013.04.011","article-title":"Analysis of the frequency and spectrum on mutation recognised to cause familial hypercholesterolaemia in routine clinical practise in a UK specialist hospital clinic","volume":"229","author":"Futema","year":"2013","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clinical Chemistry"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD006401.pub5-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacl.2011.04.003","article-title":"Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia","volume":"5","author":"Goldberg","year":"2011","journal-title":"Journal of Clinical Lipidology"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub5-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1016\/S0021-9258(18)50610-4","article-title":"Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor","volume":"254","author":"Goldstein","year":"1979","journal-title":"Journal of Biological Chemistry"},{"issue":"6257","key":"10.1002\/14651858.CD006401.pub5-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0057|cit57","first-page":"1981","article-title":"Familial hypercholesterolemia","volume-title":"The Metabolic Bases of Inherited Diseases","author":"Goldstein","year":"1995"},{"issue":"10","key":"10.1002\/14651858.CD006401.pub5-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4155\/cli.13.81","article-title":"The importance of monitoring adverse events in statin, and other, clinical trials","volume":"3","author":"Golomb","year":"2013","journal-title":"Clinica Investigation"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.atherosclerosis.2005.02.016","article-title":"Genetic screening protocol for familial hypercholesterolemia which includes splicing defects gives an improved mutation detection rate","volume":"182","author":"Graham","year":"2005","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1136\/bjo.79.11.996","article-title":"Absence of effect of simvastatin on the progression of lens opacitis in a randomised placebo controlled study. Oxford Cholesterol Study Group","volume":"79","author":"Harris","year":"1995","journal-title":"Bristish Journal of Opthalmology"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0021-9150(98)00274-3","article-title":"The type of mutation in the low density lipoprotein receptor gene influences the cholesterol-lowering response of the HMG-CoA reductase inhibitor simvastatin in patients with heterozygous familial hypercholesterolemia","volume":"143","author":"Heath","year":"1999","journal-title":"Atherosclerosis"},{"issue":"7414","key":"10.1002\/14651858.CD006401.pub5-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0063|cit63","unstructured":"Higgins JP Deeks JJ editor(s) Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0064|cit64","unstructured":"Higgins JP Altman DG editor(s) Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"c2197","DOI":"10.1136\/bmj.c2197","article-title":"Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database","volume":"340","author":"Hippisley-Cox","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0002-9149(02)02393-7","article-title":"Relation of flow-mediated vasodilatation and coronary arterial calcium in young patients with heterozygous familial hypercholesterolemia","volume":"90","author":"Hoffmann","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub5-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00109-005-0019-z","article-title":"Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing","volume":"84","author":"Humphries","year":"2006","journal-title":"Journal of Molecular Medicine (Berl)"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub5-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1136\/jmg.2006.038356","article-title":"Genetic causes of Familial Hypercholesterolaemia in UK patients: Relation to plasma lipid levels and coronary heart disease risk","volume":"43","author":"Humphries","year":"2006","journal-title":"Journal of Medical Genetics"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/humu.23634","article-title":"ClinVar database of global familial hypercholesterolemia-associated DNA variants","volume":"39","author":"Iacocca","year":"2018","journal-title":"Human Mutation"},{"issue":"12","key":"10.1002\/14651858.CD006401.pub5-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative Review: statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0071|cit71","first-page":"515","article-title":"Statin use and the risk of type 2 diabetes mellitus in children adolescents","volume":"17","author":"Joyce","year":"2017","journal-title":"Acta Pediatrica"},{"issue":"7303","key":"10.1002\/14651858.CD006401.pub5-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/bmj.323.7303.42","article-title":"Assessing the quality of controlled clinical trials","volume":"323","author":"J\u00fcni","year":"2001","journal-title":"BMJ"},{"issue":"22","key":"10.1002\/14651858.CD006401.pub5-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1016\/j.jacc.2016.03.520","article-title":"Diagnostic yield and clinical utility of sequencing familial hypercholesterolemia genes in patients with severe hypercholesterolemia","volume":"67","author":"Khera","year":"2016","journal-title":"Journal American College of Cardiology"},{"issue":"20","key":"10.1002\/14651858.CD006401.pub5-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1161\/CIRCULATIONAHA.105.565507","article-title":"Low-density lipoprotein receptor genotype and response to pravastatin in children with familial hypercholesterolemia: substudy of an intima-media thickness trial","volume":"112","author":"Koeijvoets","year":"2005","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD006401.pub5-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1161\/01.ATV.13.10.1460","article-title":"Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations","volume":"13","author":"Kotze","year":"1993","journal-title":"Arteriosclerosis and Thrombosis"},{"issue":"10","key":"10.1002\/14651858.CD006401.pub5-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1001\/jama.2014.8892","article-title":"Ten-year follow-up after initiation of statin therapy in children with familial hyeprcholesterolemia","volume":"312","author":"Kusters","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1172\/JCI107670","article-title":"Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood","volume":"53","author":"Kwiterovich","year":"1974","journal-title":"Journal of Clinical Investigation"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub5-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"52C","DOI":"10.1016\/j.amjcard.2005.12.010","article-title":"Statin safety: A systematic review","volume":"97","author":"Law","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmedgenet-2016-104054","article-title":"The UCL low-density lipoprotein receptor gene variant database: pathogenicity update","volume":"54","author":"Leigh","year":"2016","journal-title":"Journal of Medical Genetics"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1136\/adc.51.11.842","article-title":"Screening for familial hyper-beta-lipoproteinemia in children in hospital","volume":"51","author":"Leonard","year":"1976","journal-title":"Archives of Diseases in Children"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jamaophthalmol.2013.4575","article-title":"Association of statin use with cataracts: a propensity score-matched analysis","volume":"131","author":"Leuschen","year":"2013","journal-title":"JAMA Opthalmolology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/01.CIR.79.2.225","article-title":"Development of coronary heart disease in familial hypercholesterolemia","volume":"79","author":"Mabuchi","year":"1989","journal-title":"Circulation"},{"issue":"14","key":"10.1002\/14651858.CD006401.pub5-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1161\/CIRCULATIONAHA.107.181946","article-title":"Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing","volume":"115","author":"McCrindle","year":"2007","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MOL.0b013e3283587522","article-title":"Familial hypercholesterolemia in children and adolescents","volume":"23","author":"McCrindle","year":"2012","journal-title":"Current Opinion in Lipidology"},{"issue":"8A","key":"10.1002\/14651858.CD006401.pub5-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"89C","DOI":"10.1016\/j.amjcard.2006.02.030","article-title":"Final conclusions and recommendations of the National Lipid Association Statin Safety Task Force","volume":"97","author":"McKenney","year":"2006","journal-title":"American Journal of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01213011-200504000-00005","article-title":"Genetic and environmental factors affecting the response to statin therapy in patients with molecularly defined familial hypercholesterolaemia","volume":"15","author":"Miltiadous","year":"2005","journal-title":"Pharmagogenetic Genomics"},{"issue":"1-2","key":"10.1002\/14651858.CD006401.pub5-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0021-9150(93)90171-P","article-title":"Familial defective apolipoprotein B-100: A review, including some comparisons with familial hypercholesterolaemia","volume":"104","author":"Myant","year":"1993","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub5-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.amjcard.2012.12.037","article-title":"Meta-anaysis of impact of different types and doses of statins on new-onset diabetes mellitus","volume":"111","author":"Navarese","year":"2013","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0089|cit89","unstructured":"National Institute of Clinical Excellence Identification and management of familial hypercholesterolaemia - clinical guideline CG71 http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CG071NICEGuideline.pdf"},{"issue":"45","key":"10.1002\/14651858.CD006401.pub5-BIB0090|cit90","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"European Heart Journal"},{"issue":"6725","key":"10.1002\/14651858.CD006401.pub5-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1136\/bmj.300.6725.667","article-title":"Lipid lowering drugs","volume":"300","author":"O'Connor","year":"1990","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD006401.pub5-BIB0092|cit92","doi-asserted-by":"crossref","first-page":"505","DOI":"10.5551\/jat.34108","article-title":"International developments in the care of familial hypercholesterolemia: Where now and where to next?","volume":"23","author":"Pang","year":"2016","journal-title":"Journal of Atherosclerosis and Thrombosis"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub5-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"ACC\/AHA\/NHLBI Clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"issue":"18","key":"10.1002\/14651858.CD006401.pub5-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1001\/archinte.1996.00440170097011","article-title":"Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study","volume":"156","author":"Pedersen","year":"1996","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001918","article-title":"Dietary treatment for familial hypercholesterolaemia","author":"Poustie","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9716","key":"10.1002\/14651858.CD006401.pub5-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD006401.pub5-BIB0097|cit97","unstructured":"Scottish Intercollegiate Guidelines Network Risk estimation and the prevention of cardiovascular disease www.sign.ac.uk\/pdf\/sign97.pdf"},{"issue":"9","key":"10.1002\/14651858.CD006401.pub5-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2014.08.047","article-title":"Statin therapy and risk of diabetes in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia","volume":"237","author":"Skoumas","year":"2014","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub5-BIB0100|cit100","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJM200202143460721","article-title":"Cerivastatin and reports of fatal rhabdomyolysis","volume":"346","author":"Staffa","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1515\/CCLM.2008.135","article-title":"Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing","volume":"46","author":"Starr","year":"2008","journal-title":"Clinical Chemistry and Laboratory Medicine"},{"issue":"3","key":"10.1002\/14651858.CD006401.pub5-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.hlc.2011.11.006","article-title":"INTERIM guidelines for the diagnosis and management of familial hypercholesterolaemia","volume":"21","author":"Sullivan","year":"2012","journal-title":"Heart Lung and Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0021-9150(97)00181-0","article-title":"Influence of genotype at the low density lipoprotein (LDL) receptor gene locus on the clinical phenotype and response to lipid-lowering drug therapy in heterozygous familial hypercholesterolemia. The Familial Hypercholesterolaemia Regression Study Group","volume":"136","author":"Sun","year":"1998","journal-title":"Atherosclerosis"},{"issue":"9965","key":"10.1002\/14651858.CD006401.pub5-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"issue":"9874","key":"10.1002\/14651858.CD006401.pub5-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD006401.pub5-BIB0106|cit106","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1161\/01.ATV.16.8.984","article-title":"Risk factors related to carotid intima-media thickness and plaque in children with familial hypercholesterolemia and control subjects","volume":"16","author":"Tonstad","year":"1996","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"24","key":"10.1002\/14651858.CD006401.pub5-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1161\/01.CIR.0000041253.61683.08","article-title":"Low-density lipoprotein receptor gene mutations and cardiovascular risk in a large genetic cascade screening population","volume":"106","author":"Umans-Eckenhausen","year":"2002","journal-title":"Circulation"},{"issue":"11","key":"10.1002\/14651858.CD006401.pub5-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.110.979450","article-title":"Molecular basis of autosomal dominant hypercholesterolemia","volume":"123","author":"Graaf","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1002\/14651858.CD006401.pub5-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00246-013-0742-0","article-title":"Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia","volume":"35","author":"Vlahos","year":"2014","journal-title":"Pediatric Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0110|cit110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0021-9150(01)00584-6","article-title":"Influence of LDL receptor gene mutation and apo E polymorphis on liporpotein response to simvastatin treatment among adolescents with heterozygous familial hypercholesterolemia","volume":"160","author":"Vohl","year":"2002","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1002\/14651858.CD006401.pub5-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3109\/07853890108995954","article-title":"Familial hypercholesterolaemia in Finland: Common, rare and mild mutations of the LDL receptor and their clinical consequences","volume":"33","author":"Vuorio","year":"2001","journal-title":"Annals of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.atherosclerosis.2012.10.032","article-title":"Statin treatment of children with familial hypercholesterolemia - trying to balance incomplete evidence of long-term safety and clinical accountability: Are we approaching a consensus?","volume":"226","author":"Vuorio","year":"2013","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1002\/14651858.CD006401.pub5-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/joim.12405","article-title":"Statins and new-onset diabetes mellitus - a risk lacking in familial hypercholesterolaemia","volume":"279","author":"Vuorio","year":"2016","journal-title":"Journal of Internal Medicine"},{"issue":"17","key":"10.1002\/14651858.CD006401.pub5-BIB0114|cit114","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD006401.pub5-BIB0115|cit115","first-page":"115","article-title":"Screening for hyperlipidaemia in childhood. Recommendations of the British Hyperlipidaemia Association","volume":"30","author":"Wray","year":"1996","journal-title":"Journal of Royal College of Physicians London"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub5-BIB0116|cit116","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006401.pub2","article-title":"Statins for children with familial hypercholesterolemia","author":"Vuorio","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub5-BIB0117|cit117","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006401.pub3","article-title":"Statins for children with familial hypercholesterolemia","author":"Vuorio","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD006401.pub5-BIB0118|cit118","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006401.pub3","article-title":"Statins for children with familial hypercholesterolemia","author":"Vuorio","year":"2017","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD006401.pub5\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,3]],"date-time":"2022-10-03T18:04:36Z","timestamp":1664820276000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD006401.pub5"}},"subtitle":[],"editor":[{"name":"Cochrane Cystic Fibrosis and Genetic Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,7]]},"references-count":118,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd006401.pub5","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,7]]}}}